Moreover, intracardiac pretreatment with AT1R antisense prevented the development of hypertension and cardiac hypertrophy and reduced cardiovascular contractility in SHR exposed to chronic infusion of Ang II [74]. The gene discussed is AGT; the disease is cardiac hypertrophy.